BGA — BioNeutra Global Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for BioNeutra Global, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-12.4	-3.71	-2.83	-2.92	-2.11
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	0.527	0.46	1	0.209	0.036
Unusual Items
Other Non-Cash Items
Changes in Working Capital	10.7	2.84	0.777	2.44	1.7
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	0.708	1.43	0.271	0.838	0.683
Capital Expenditures	-0.237	-0.076	-0.277	-0.204	-0.019
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0.516	0.05	0	0.006	-0.001
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities	0.278	-0.026	-0.277	-0.197	-0.021
Financing Cash Flow Items	-0.534	-0.387	-0.35	-0.439	-0.66
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-1.66	-0.9	-0.298	-0.309	0.446
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-0.974	0.411	-0.095	-0.117	1.17